PsyMed Ventures Newsletter

Share this post

DMTweet: a psychedelic tweet recap

psymedventures.substack.com

DMTweet: a psychedelic tweet recap

a PsyMed Ventures x Business Trip colab (issue #8)

PsyMed Ventures
Jun 12, 2022
1
Share this post

DMTweet: a psychedelic tweet recap

psymedventures.substack.com

DMTweet is a newsletter of psychedelic tweets that catch our eye 👀.

This is a collaboration between PsyMed Ventures and Business Trip (yes, we’re the folks working on both 🙃).

Tweets include: Industry updates 💼, Therapy 🛋️, Psychedelic research 🧪, Neuroscience 🧠, Consciousness ✨, Indigenous reciprocity ⚖️, Regulatory updates 📜, and Trippy ideas 👽.

Inclusion = interesting ≠ endorsement.

Let’s get to it….

Twitter avatar for @elonmusk
Elon Musk @elonmusk
@insidepharma @jimcramer Psychedelics and MDMA can make a real difference to mental health, especially for extreme depression and PTSD. We should take this seriously.
6:03 AM ∙ Jun 10, 2022
6,618Likes973Retweets
Twitter avatar for @RCarhartHarris
Robin Carhart-Harris @RCarhartHarris
Perhaps the term “double blind” should be dropped from the description of most clinical trials involving a psychoactive treatment arm? It only really holds if condition guess rate is chance, and it usually isn’t.
7:26 PM ∙ Jun 1, 2022
104Likes7Retweets
Twitter avatar for @psybalazs
Balazs Szigeti @psybalazs
Small step in the right direction: the #WHO joins the #UnitedNations calling to understand #Mentalhealth as a problem that is wider than a biochemical issue. tinyurl.com/mprprcsd
1:25 AM ∙ Jun 5, 2022
Twitter avatar for @jesse_yeji
Yeji Jesse Lee 이예지 @jesse_yeji
A project months in the making: Insider put together a tracker of the 18 clinical trials in the psychedelics space furthest along in the regulatory process From me & the great @drcatherinesb who came up with the idea to put this together (1/6)
businessinsider.comThe 18 clinical trials that could make or break the future of the $100 billion psychedelics industryCompanies are trying to turn psychedelics into medical treatments by testing them in clinical trials. We identified the ones closest to approval.
1:30 PM ∙ Jun 1, 2022
63Likes17Retweets
Twitter avatar for @curious_vii
christian ulstrup @curious_vii
As someone who went pretty far down the secular California style meditation path, I couldn’t agree more with @AdamMGrant There’s a lot of narcissism in the “woo” world, and it can be easy to become self-absorbed through these practices.
Image
Image
1:51 PM ∙ Jun 1, 2022
Twitter avatar for @therealbrom
brom | psychedelic VC @therealbrom
while most psychedelic companies are waiting on FDA approval or state-level decrim, Schedule 35 is just straight up selling psilocybin on the internet 🤯 they advertise openly on social media and top podcasts like Hot Boxin with @MikeTyson crazy schedule35.co
schedule35.coMagic Mushrooms Marketplace - Schedule35Schedule35 is the number one shop for premium magic mushroom and psilocybe cubensis microdose products.
6:05 PM ∙ Jun 4, 2022
48Likes9Retweets
Twitter avatar for @JvonSalm
Jackie von Salm, PhD @JvonSalm
Drugs with US FDA approval, and we still don't know how they work... Go! I'll start us off: Depakote
11:19 PM ∙ Jun 6, 2022
35Likes3Retweets

Until next time,

Greg, Matias, and Dina

🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄

DMTweet is a collab between PsyMed Ventures and Business Trip. PsyMed Ventures is a community-focused fund and syndicate investing in psychedelic medicine and mental health tech. Business Trip is a podcast about psychedelic entrepreneurship. Our mission is to help expand access to psychedelic medicine and mental health.

Share this post

DMTweet: a psychedelic tweet recap

psymedventures.substack.com
Comments
TopNewCommunity

No posts

Ready for more?

© 2023 Business Trip
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing